Citius Oncology Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 8.71 M | $5.66 M | -5.26% | 8.07% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 3.84 M | $2.49 M | 0.00% | 3.55% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 546.33 K | $355.11 K | 2.15% | 0.51% |
| UBS GROUP AG | 08/13/2026 | 334.62 K | $217.50 K | 808.30% | 0.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 245.41 K | $159.54 K | -7.30% | 0.23% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 121.91 K | $79.24 K | 0.00% | 0.11% |
| IFP ADVISORS, INC | 07/20/2026 | 107.42 K | $69.84 K | 0.00% | 0.10% |
| CITADEL ADVISORS LLC | 09/02/2026 | 90.59 K | $58.89 K | 100.00% | 0.08% |
| NORTHERN TRUST CORP | 08/13/2026 | 45.75 K | $29.74 K | 0.00% | 0.04% |
| STATE STREET CORP | 09/22/2026 | 42.90 K | $27.89 K | 0.00% | 0.04% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 21.88 K | $14.00 K | 100.00% | 0.02% |
| XTX TOPCO LTD | 08/14/2026 | 20.64 K | $13.42 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 13.82 K | $8.98 K | 100.00% | 0.01% |
| ARKADIOS WEALTH ADVISORS | 08/10/2026 | 11.67 K | $7.58 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 1.00 K | $650 | -90.12% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 500 | $325 | 100.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 200 | $130 | 100.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 90 | $59 | 100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 23 | $15 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 1 | $1 | 0.00% | 0.00% |
| BLACKROCK, INC. | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Citius Oncology Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Citius Oncology Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 8.71 M
BANK OF AMERICA CORP /DE/: 3.84 M
VANGUARD CAPITAL MANAGEMENT LLC: 546,325
UBS Group AG: 334,619
GEODE CAPITAL MANAGEMENT, LLC: 245,407
VANGUARD FIDUCIARY TRUST CO: 121,910
13.11% of Citius Oncology Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.74 M shares in the last 24 months. This purchase volume represents approximately $14.89 M in transactions.